Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
112,239,402
-
Share change
-
+2,870,343
-
Total reported value
-
$19,027,485,774
-
Put/Call ratio
-
86%
-
Price per share
-
$169.52
-
Number of holders
-
390
-
Value change
-
+$501,915,844
-
Number of buys
-
191
-
Number of sells
-
170
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q2 2021
As of 30 Jun 2021,
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) was held by
390 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
112,239,402 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Dodge & Cox, STATE STREET CORP, JPMORGAN CHASE & CO, and MORGAN STANLEY.
This page lists
390
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.